The serum concentration of Rosuvastatin can be increased when it is combined with Methylergometrine. The metabolism of Rosuvastatin can be increased when combined with Primidone. The metabolism of Rosuvastatin can be decreased when combined with Bortezomib. The risk or severity of adverse effects can be increased when Azimilide is combined with Rosuvastatin. The risk or severity of adverse effects can be increased when Niguldipine is combined with Rosuvastatin. The risk or severity of adverse effects can be increased when Naftopidil is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Azelastine. The serum concentration of Rosuvastatin can be increased when it is combined with Vinorelbine. The serum concentration of Rosuvastatin can be increased when it is combined with Clopidogrel. The serum concentration of Rosuvastatin can be increased when it is combined with Phosphoramidon. The metabolism of Rosuvastatin can be increased when combined with Pentobarbital. The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Mecamylamine. The risk or severity of adverse effects can be increased when Metergoline is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Methylprednisolone. The serum concentration of Rosuvastatin can be increased when it is combined with Linagliptin. The metabolism of Rosuvastatin can be increased when combined with St. John's Wort. The serum concentration of Rosuvastatin can be increased when it is combined with Fluticasone propionate. The serum concentration of Rosuvastatin can be increased when it is combined with Methimazole. The risk or severity of adverse effects can be increased when Butoconazole is combined with Rosuvastatin. The metabolism of Rosuvastatin can be decreased when combined with Floxuridine. The serum concentration of Rosuvastatin can be increased when it is combined with Terfenadine. The metabolism of Rosuvastatin can be decreased when combined with Zucapsaicin. The metabolism of Rosuvastatin can be decreased when combined with Isoniazid. The serum concentration of Rosuvastatin can be increased when it is combined with Cilastatin. The risk or severity of adverse effects can be increased when Sertaconazole is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline. The serum concentration of Rosuvastatin can be decreased when it is combined with Lumacaftor. Rosuvastatin may increase the anticoagulant activities of Phenindione. The serum concentration of Rosuvastatin can be increased when it is combined with Dasabuvir. The serum concentration of Tolvaptan can be increased when it is combined with Rosuvastatin. The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Daptomycin. The serum concentration of Rosuvastatin can be increased when it is combined with Tacrolimus. The serum concentration of Rosuvastatin can be increased when it is combined with Saxagliptin. The serum concentration of Rosuvastatin can be decreased when it is combined with Magnesium Hydroxide. The metabolism of Rosuvastatin can be decreased when combined with Amiodarone. The metabolism of Rosuvastatin can be decreased when combined with Voriconazole. The serum concentration of Rosuvastatin can be increased when it is combined with Levofloxacin. The risk or severity of adverse effects can be increased when Perhexiline is combined with Rosuvastatin. The risk or severity of adverse effects can be increased when Lysergic Acid Diethylamide is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Edoxaban. The serum concentration of Pitavastatin can be increased when it is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Indinavir. The serum concentration of Rosuvastatin can be increased when it is combined with Testosterone. Acipimox may increase the myopathic rhabdomyolysis activities of Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Imidapril. The serum concentration of Rosuvastatin can be increased when it is combined with Osimertinib. The metabolism of Rosuvastatin can be decreased when combined with Olaparib. The serum concentration of Rosuvastatin can be increased when it is combined with Enalkiren. The metabolism of Rosuvastatin can be decreased when combined with Delavirdine. The metabolism of Rosuvastatin can be decreased when combined with Topiroxostat. The serum concentration of Rosuvastatin can be increased when it is combined with Rabeprazole. The metabolism of Rosuvastatin can be decreased when combined with Fluvoxamine. The serum concentration of Rosuvastatin can be increased when it is combined with Sulfinpyrazone. The serum concentration of Rosuvastatin can be increased when it is combined with Fusidic Acid. The metabolism of Rosuvastatin can be decreased when combined with Efavirenz. The metabolism of Rosuvastatin can be decreased when combined with Nicardipine. The serum concentration of Rosuvastatin can be increased when it is combined with Doxorubicin. The metabolism of Rosuvastatin can be decreased when combined with Doxycycline. The serum concentration of Rosuvastatin can be decreased when it is combined with Vemurafenib. The serum concentration of Rosuvastatin can be increased when it is combined with 4-(2-Aminoethyl)Benzenesulfonyl Fluoride. The serum concentration of Rosuvastatin can be decreased when it is combined with Eslicarbazepine acetate. The risk or severity of adverse effects can be increased when Spiramycin is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Astemizole. The serum concentration of Rosuvastatin can be increased when it is combined with Diethylstilbestrol. The serum concentration of Rosuvastatin can be increased when it is combined with Mifepristone. The serum concentration of Ubidecarenone can be increased when it is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Daunorubicin. The serum concentration of Rosuvastatin can be increased when it is combined with Dalfopristin. The serum concentration of Rosuvastatin can be increased when it is combined with Palbociclib. The serum concentration of Rosuvastatin can be increased when it is combined with Dronedarone. The risk or severity of adverse effects can be increased when Methysergide is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be decreased when it is combined with Almasilate. The serum concentration of Rosuvastatin can be increased when it is combined with Glyburide. The serum concentration of Rosuvastatin can be increased when it is combined with Trandolapril. The serum concentration of Rosuvastatin can be increased when it is combined with Quinapril. The risk or severity of adverse effects can be increased when Pinaverium is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Mirtazapine. The serum concentration of Rosuvastatin can be increased when it is combined with Sulfanilamide. The risk or severity of adverse effects can be increased when Nimesulide is combined with Rosuvastatin. The risk or severity of adverse effects can be increased when Sulconazole is combined with Rosuvastatin. The metabolism of Rosuvastatin can be decreased when combined with Clemastine. The risk or severity of adverse effects can be increased when Tranilast is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be decreased when it is combined with Phenytoin. Rosuvastatin may increase the anticoagulant activities of Ethyl biscoumacetate. The metabolism of Rosuvastatin can be decreased when combined with Imatinib. The serum concentration of Rosuvastatin can be increased when it is combined with Capsaicin. The risk or severity of adverse effects can be increased when Benidipine is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Dexamethasone. The serum concentration of Rosuvastatin can be increased when it is combined with Atazanavir. The metabolism of Rosuvastatin can be decreased when combined with Tolbutamide. The serum concentration of Rosuvastatin can be increased when it is combined with Metronidazole. The serum concentration of Rosuvastatin can be increased when it is combined with Enalaprilat. The serum concentration of Rosuvastatin can be increased when it is combined with Haloperidol. The metabolism of Rosuvastatin can be decreased when combined with Manidipine. The serum concentration of Rosuvastatin can be increased when it is combined with Tetracycline. The serum concentration of Rosuvastatin can be increased when it is combined with Desipramine. The risk or severity of adverse effects can be increased when Lisuride is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Josamycin. The risk or severity of adverse effects can be increased when Isavuconazole is combined with Rosuvastatin. The metabolism of Rosuvastatin can be decreased when combined with Cobicistat. The serum concentration of Rosuvastatin can be increased when it is combined with Pravastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Prednisone. The risk or severity of adverse effects can be increased when Bepridil is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Raloxifene. The serum concentration of Lanthanum carbonate can be decreased when it is combined with Rosuvastatin. The metabolism of Rosuvastatin can be increased when combined with Carbamazepine. The metabolism of Rosuvastatin can be decreased when combined with Irbesartan. The serum concentration of Rosuvastatin can be increased when it is combined with Ombitasvir. The serum concentration of Rosuvastatin can be increased when it is combined with GM6001. The serum concentration of Rosuvastatin can be increased when it is combined with Sivelestat. The risk or severity of adverse effects can be increased when Terconazole is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Cyclosporine. The serum concentration of Rosuvastatin can be increased when it is combined with Ethanol. The risk or severity of adverse effects can be increased when Albaconazole is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Danazol. The serum concentration of Rosuvastatin can be increased when it is combined with Midazolam. The serum concentration of Rosuvastatin can be increased when it is combined with Lisinopril. The metabolism of Rosuvastatin can be decreased when combined with Rucaparib. The serum concentration of Rosuvastatin can be increased when it is combined with Cyproterone acetate. The serum concentration of Rosuvastatin can be increased when it is combined with Lercanidipine. The serum concentration of Rosuvastatin can be increased when it is combined with Paclitaxel. The serum concentration of Rosuvastatin can be increased when it is combined with Dasatinib. The serum concentration of Rosuvastatin can be increased when it is combined with Clofazimine. The serum concentration of Rosuvastatin can be increased when it is combined with Ifosfamide. The serum concentration of Rosuvastatin can be increased when it is combined with Benzamidine. The serum concentration of Rosuvastatin can be increased when it is combined with Aldesleukin. The risk or severity of adverse effects can be increased when Clevidipine is combined with Rosuvastatin. The risk or severity of adverse effects can be increased when Gallopamil is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Oxymetholone. The serum concentration of Rosuvastatin can be increased when it is combined with Darunavir.